guest ::
Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults – results from the ActiFE study
; ; ; ; ; ;
In
European journal of clinical pharmacology 82(8), Seiten/Artikel-Nr.:225
2026
Online
DOI: 10.1007/s00228-026-04155-y
DOI: 10.18154/RWTH-2026-07947
URL: https://publications.rwth-aachen.de/record/1040489/files/1040489.pdf
Einrichtungen
Projekte
- OAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF) (021000-OAPKF)
- DFG project G:(GEPRIS)450627322 - SFB 1506: Alterung an Schnittstellen (450627322) (450627322)
- SafePolyMed - Improve Safety in Polymedication by Managing Drug-Drug-Gene Interactions (101057639) (101057639)
Thematische Einordnung (Klassifikation)
DDC: 610
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-105046519635
WOS Core Collection: WOS:001838785000001
Interne Identnummern
RWTH-2026-07947
Datensatz-ID: 1040489
Beteiligte Länder
Germany, USA
; 
; 
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
| Typ | Amount | VAT | Currency | Share | Status | Cost centre |
| Hybrid-OA | 2600.00 | 182.00 | EUR | 96.76 % | (DEAL) | 021000-923310 |
| Other | 87.00 | 6.09 | EUR | 3.24 % | (DEAL) | 021000-923310 |
| Sum | 2687.00 | 188.09 | EUR | |||
| Total | 2875.09 |
PDF